KATHI NIFFENEGGER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KATHI NIFFENEGGER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KATHI NIFFENEGGER. KATHI NIFFENEGGER is Chief Financial Officer in Stellar Biotechnologies, Inc. ($SBOT).
Latest Insider Trading Transactions of KATHI NIFFENEGGER
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 26 2021 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 5.45 | 80,000 | 436,000 | 80,000 | |
| Nov 09 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | X | 4.00 | 609 | 2,436 | 0 | |
| Nov 09 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Buy | X | 4.00 | 609 | 2,436 | 1,827 | 1.2 K to 1.8 K (+50.00 %) |
| Oct 14 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 7.44 | 50,000 | 372,000 | 50,000 | |
| Feb 14 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 3.16 | 88,699 | 280,289 | 88,699 | |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 4.00 | 609 | 2,436 | 609 | |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 4.80 | 914 | 4,387 | 914 | |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Grant | A | 4.11 | 1,218 | 5,006 | 1,218 | 0 to 1.2 K |
| Mar 14 2018 | SBOT | Stellar Biotechnol ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 0.84 | 35,000 | 29,400 | 35,000 | |
| Dec 21 2016 | SBOT | Stellar Biotechnol ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 2.03 | 10,000 | 20,300 | 10,000 | |
| Dec 23 2015 | SBOT | Stellar Biotechnol ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 7.24 | 10,000 | 72,400 | 10,000 | |
| Nov 13 2014 | SBOT | Stellar Biotechnol ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 1.34 | 90,000 | 120,951 | 90,000 |
Page: 1